Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Burkholderia pseudomallei O-polysaccharide (OPS) is a critical surface component of the Gram-negative bacterium responsible for melioidosis, a severe and often fatal tropical disease. The OPS is a linear polymer consisting of repeating units of 1,3-linked 2-O-acetyl-6-deoxy-beta-D-manno-heptopyranose residues, which plays a vital role in the pathogen's ability to evade the host's innate immune system by providing resistance to complement-mediated lysis. Because of its high exposure on the bacterial surface and its role as a dominant antigen during infection, it is a primary target for the development of diagnostic assays and prophylactic vaccines. In therapeutic development, OPS is frequently utilized as the carbohydrate component in conjugate vaccines, where it is chemically linked to carrier proteins to elicit a robust T-cell dependent immune response. Monoclonal antibodies targeting specific epitopes of the OPS have also demonstrated protective efficacy in animal models, highlighting its potential as a target for passive immunotherapy. Diagnostic tools, such as lateral flow assays, utilize anti-OPS antibodies to detect the presence of the antigen in clinical samples, providing a rapid means of identifying B. pseudomallei infections in endemic regions.
Induction of protective humoral immunity through the production of opsonizing antibodies that facilitate phagocytosis and neutralization of the bacteria.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Burkholderia pseudomallei O-polysaccharide (Bp OPS).